The iconic success of Viagra, produced by copyright, undeniably revolutionized the management of erectile dysfunctionality, and fueled a massive growth in the drug sector. However, now, investing in companies reliant on aging blockbuster drugs like Viagra presents a challenging landscape. Off-brand competition is aggressive, substantially diminishi